By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Orchid Cellmark today announced the two-year extension of contracts previously awarded under the North West/South West and Wales regional forensic tender process in the UK.

The contracts, originally awarded in April 2008, were set to expire in 2011 and have been extended to 2013. In total, the contracts have a value of about $10 million, the company said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.